$11.4 Billion is the total value of Orbimed Advisors's 149 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 35.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRLD | PRELUDE THERAPEUTICS INC | $1,115,813,000 | +137.5% | 15,594,877 | 0.0% | 9.76% | +65.3% | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $537,105,000 | +52.1% | 7,406,307 | 0.0% | 4.70% | +5.9% | |
| PMVP | PMV PHARMACEUTICALS INC | $450,894,000 | +73.3% | 7,330,423 | 0.0% | 3.95% | +20.6% | |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $405,053,000 | – | 8,740,887 | +100.0% | 3.54% | – |
| ABCL | New | ABCELLERA BIOLOGICS INC | $338,047,000 | – | 8,400,768 | +100.0% | 2.96% | – |
| TPTX | TURNING POINT THERAPEUTICS I | $334,518,000 | +39.5% | 2,745,327 | 0.0% | 2.93% | -2.9% | |
| PRVL | PREVAIL THERAPEUTICS INC | $318,884,000 | +126.6% | 13,822,463 | 0.0% | 2.79% | +57.7% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $308,333,000 | +40.9% | 6,645,100 | 0.0% | 2.70% | -1.9% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $251,554,000 | +15.0% | 1,145,300 | -13.0% | 2.20% | -19.9% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $234,502,000 | +26.6% | 6,523,000 | +34.6% | 2.05% | -11.9% |
| BMY | BRISTOL-MYERS SQUIBB CO | $220,151,000 | +2.9% | 3,549,100 | 0.0% | 1.93% | -28.4% | |
| HZNP | HORIZON THERAPEUTICS PUB L | $220,090,000 | -5.8% | 3,008,755 | 0.0% | 1.93% | -34.4% | |
| MRK | Buy | MERCK & CO. INC | $217,531,000 | +1.3% | 2,659,300 | +2.7% | 1.90% | -29.5% |
| NTRA | NATERA INC | $210,057,000 | +37.8% | 2,110,700 | 0.0% | 1.84% | -4.1% | |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $197,131,000 | +8.8% | 834,100 | +25.2% | 1.72% | -24.3% |
| PASG | PASSAGE BIO INC | $178,041,000 | +95.0% | 6,962,899 | 0.0% | 1.56% | +35.8% | |
| ARQT | Buy | ARCUTIS BIOTHERAPEUTICS INC | $170,857,000 | +24.8% | 6,073,850 | +30.0% | 1.50% | -13.1% |
| AFIB | ACUTUS MED INC | $157,820,000 | -3.3% | 5,477,958 | 0.0% | 1.38% | -32.7% | |
| KNTE | New | KINNATE BIOPHARMA INC | $153,071,000 | – | 3,847,929 | +100.0% | 1.34% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $136,870,000 | – | 390,300 | +100.0% | 1.20% | – |
| PFE | New | PFIZER INC | $133,127,000 | – | 3,616,600 | +100.0% | 1.16% | – |
| GRAY | GRAYBUG VISION INC | $129,889,000 | +128.3% | 4,475,847 | 0.0% | 1.14% | +59.0% | |
| BIIB | Sell | BIOGEN INC | $129,629,000 | -36.2% | 529,400 | -26.1% | 1.13% | -55.6% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $124,769,000 | -0.3% | 1,301,715 | 0.0% | 1.09% | -30.6% | |
| CNC | Buy | CENTENE CORP DEL | $119,682,000 | +53.6% | 1,993,700 | +49.3% | 1.05% | +6.9% |
| KROS | KEROS THERAPEUTICS INC | $118,466,000 | +82.9% | 1,679,417 | 0.0% | 1.04% | +27.4% | |
| RPTX | REPARE THERAPEUTICS INC | $117,523,000 | +11.5% | 3,426,325 | 0.0% | 1.03% | -22.4% | |
| HUM | Buy | HUMANA INC | $117,378,000 | +1.2% | 286,100 | +2.1% | 1.03% | -29.6% |
| TBPH | THERAVANCE BIOPHARMA INC | $110,514,000 | +20.2% | 6,219,110 | 0.0% | 0.97% | -16.3% | |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $108,807,000 | +105.7% | 1,626,900 | +37.5% | 0.95% | +43.2% |
| DXCM | Buy | DEXCOM INC | $103,189,000 | +10.6% | 279,100 | +23.3% | 0.90% | -23.0% |
| ANTM | New | ANTHEM INC | $99,698,000 | – | 310,500 | +100.0% | 0.87% | – |
| ORIC | ORIC PHARMACEUTICALS INC | $98,909,000 | +35.3% | 2,921,967 | 0.0% | 0.86% | -5.9% | |
| BNR | Sell | BURNING ROCK BIOTECH LTDsponsored ads | $96,135,000 | -19.2% | 4,161,675 | -12.3% | 0.84% | -43.8% |
| AGIO | AGIOS PHARMACEUTICALS INC | $95,643,000 | +23.8% | 2,207,321 | 0.0% | 0.84% | -13.8% | |
| ACET | ADICET BIO INC | $94,255,000 | +18.2% | 6,708,507 | 0.0% | 0.82% | -17.7% | |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $93,584,000 | +65.9% | 1,025,800 | +45.2% | 0.82% | +15.5% |
| ABBV | Buy | ABBVIE INC | $92,395,000 | +127.3% | 862,300 | +85.8% | 0.81% | +58.1% |
| ISRG | INTUITIVE SURGICAL INC | $92,282,000 | +15.3% | 112,800 | 0.0% | 0.81% | -19.7% | |
| SRPT | SAREPTA THERAPEUTICS INC | $91,902,000 | +21.4% | 539,049 | 0.0% | 0.80% | -15.5% | |
| ETNB | 89BIO INC | $90,887,000 | -5.0% | 3,729,442 | 0.0% | 0.80% | -33.9% | |
| XTNT | Buy | XTANT MED HLDGS INC | $87,080,000 | +1043.1% | 72,803,072 | +687.2% | 0.76% | +693.8% |
| SVA | SINOVAC BIOTECH LTD | $72,000,000 | +163.7% | 2,839,500 | 0.0% | 0.63% | +83.7% | |
| PGNY | PROGYNY INC | $71,024,000 | +44.0% | 1,675,500 | 0.0% | 0.62% | +0.2% | |
| GH | Buy | GUARDANT HEALTH INC | $69,363,000 | +302.2% | 538,200 | +248.8% | 0.61% | +179.7% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $69,175,000 | +31.3% | 451,800 | -28.3% | 0.60% | -8.6% |
| ATRC | ATRICURE INC | $68,373,000 | +39.5% | 1,228,189 | 0.0% | 0.60% | -2.9% | |
| TCDA | TRICIDA INC | $67,781,000 | -22.2% | 9,614,280 | 0.0% | 0.59% | -45.8% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $65,748,000 | -6.1% | 4,754,000 | 0.0% | 0.58% | -34.7% | |
| LOGC | Buy | LOGICBIO THERAPEUTICS INC | $64,602,000 | +10.0% | 8,466,783 | +30.9% | 0.56% | -23.4% |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $64,244,000 | +11.2% | 1,125,700 | 0.0% | 0.56% | -22.6% | |
| MGTX | Buy | MEIRAGTX HLDGS PLC | $62,118,000 | +26.3% | 4,102,925 | +10.5% | 0.54% | -12.0% |
| IMRA | IMARA INC | $59,974,000 | +8.4% | 2,719,902 | 0.0% | 0.52% | -24.5% | |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $59,632,000 | +26.3% | 5,501,144 | +20.0% | 0.52% | -12.0% |
| EHTH | Buy | EHEALTH INC | $59,598,000 | +18.1% | 844,046 | +32.2% | 0.52% | -17.7% |
| CHNG | CHANGE HEALTHCARE INC | $57,698,000 | +28.5% | 3,093,700 | 0.0% | 0.50% | -10.5% | |
| SYK | STRYKER CORPORATION | $57,584,000 | +17.6% | 235,000 | 0.0% | 0.50% | -18.0% | |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $56,121,000 | -50.5% | 336,500 | -54.2% | 0.49% | -65.5% |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDGS | $55,530,000 | +109.3% | 1,280,086 | +106.9% | 0.49% | +45.5% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $52,027,000 | +58.4% | 1,035,160 | -7.1% | 0.46% | +10.2% |
| TMO | THERMO FISHER SCIENTIFIC INC | $51,376,000 | +5.5% | 110,300 | 0.0% | 0.45% | -26.5% | |
| GLTO | New | GALECTO INC | $51,178,000 | – | 4,090,937 | +100.0% | 0.45% | – |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $49,463,000 | – | 13,816,488 | +100.0% | 0.43% | – |
| TELA | TELA BIO INC | $45,534,000 | -9.1% | 3,027,542 | 0.0% | 0.40% | -36.7% | |
| Buy | TRILLIUM THERAPEUTICS INC | $43,545,000 | +144.6% | 2,960,200 | +136.3% | 0.38% | +70.1% | |
| SIBN | SI BONE INC | $40,918,000 | +26.1% | 1,368,500 | 0.0% | 0.36% | -12.3% | |
| ATNX | Sell | ATHENEX INC | $40,856,000 | -15.1% | 3,694,061 | -7.1% | 0.36% | -40.8% |
| VRNA | VERONA PHARMA PLCsponsored ads | $39,864,000 | +12.2% | 5,694,841 | 0.0% | 0.35% | -21.9% | |
| APLT | Buy | APPLIED THERAPEUTICS INC | $38,998,000 | +21.5% | 1,771,831 | +14.6% | 0.34% | -15.6% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $38,853,000 | -10.0% | 2,753,567 | 0.0% | 0.34% | -37.3% | |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $38,694,000 | +19.9% | 3,070,955 | -16.3% | 0.34% | -16.5% |
| XENE | XENON PHARMACEUTICALS INC | $38,418,000 | +38.9% | 2,497,917 | 0.0% | 0.34% | -3.4% | |
| FUSN | FUSION PHARMACEUTICALS INC | $37,891,000 | -2.2% | 3,224,770 | 0.0% | 0.33% | -31.8% | |
| KALA | KALA PHARMACEUTICALS INC | $37,053,000 | -9.6% | 5,465,030 | 0.0% | 0.32% | -37.1% | |
| CRIS | Buy | CURIS INC | $35,762,000 | +2361.3% | 4,366,494 | +251.7% | 0.31% | +1638.9% |
| Buy | APTOSE BIOSCIENCES INC | $35,171,000 | +553.1% | 8,030,000 | +794.7% | 0.31% | +352.9% | |
| QURE | UNIQURE NV | $35,013,000 | -1.9% | 969,079 | 0.0% | 0.31% | -31.8% | |
| MOH | New | MOLINA HEALTHCARE INC | $34,539,000 | – | 162,400 | +100.0% | 0.30% | – |
| ALEC | Sell | ALECTOR INC | $33,602,000 | +17.0% | 2,225,313 | -18.3% | 0.29% | -18.6% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $31,602,000 | +11.0% | 4,015,524 | 0.0% | 0.28% | -22.6% | |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $31,300,000 | – | 650,992 | +100.0% | 0.27% | – |
| CTIC | CTI BIOPHARMA CORP | $30,656,000 | +49.8% | 9,520,600 | 0.0% | 0.27% | +4.3% | |
| HARP | HARPOON THERAPEUTICS INC | $30,491,000 | -2.2% | 1,835,704 | 0.0% | 0.27% | -31.9% | |
| NXTC | NEXTCURE INC | $29,550,000 | +23.9% | 2,711,013 | 0.0% | 0.26% | -13.7% | |
| IMAB | I MABsponsored ads | $28,576,000 | +0.3% | 606,070 | 0.0% | 0.25% | -30.2% | |
| OSH | Buy | OAK STR HEALTH INC | $27,406,000 | +53.4% | 448,100 | +34.0% | 0.24% | +6.7% |
| FLXN | Buy | FLEXION THERAPEUTICS INC | $26,635,000 | +51.9% | 2,308,083 | +37.1% | 0.23% | +5.9% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $26,405,000 | -89.4% | 169,000 | -92.3% | 0.23% | -92.6% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $26,041,000 | +61.3% | 1,170,900 | +7.0% | 0.23% | +12.3% |
| SCPH | SCPHARMACEUTICALS INC | $25,377,000 | -29.0% | 4,797,148 | 0.0% | 0.22% | -50.6% | |
| HRTX | HERON THERAPEUTICS INC | $25,225,000 | +42.8% | 1,191,846 | 0.0% | 0.22% | -0.5% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $24,093,000 | -11.2% | 6,767,584 | 0.0% | 0.21% | -38.1% | |
| SRRA | SIERRA ONCOLOGY INC | $23,681,000 | +50.2% | 1,477,320 | 0.0% | 0.21% | +4.5% | |
| FLDM | Buy | FLUIDIGM CORP DEL | $23,354,000 | -11.6% | 3,892,346 | +9.5% | 0.20% | -38.6% |
| ALC | ALCON AG | $23,357,000 | +17.1% | 351,380 | 0.0% | 0.20% | -18.7% | |
| NMTR | 9 METERS BIOPHARMA INC | $22,091,000 | +7.8% | 25,716,755 | 0.0% | 0.19% | -25.2% | |
| PAND | PANDION THERAPEUTICS INC | $21,992,000 | +29.6% | 1,480,940 | 0.0% | 0.19% | -9.9% | |
| PRTA | Sell | PROTHENA CORP PLC | $21,587,000 | -39.0% | 1,797,458 | -49.3% | 0.19% | -57.5% |
| AMGN | AMGEN INC | $21,038,000 | -9.5% | 91,500 | 0.0% | 0.18% | -37.0% | |
| OTIC | OTONOMY INC | $21,028,000 | +59.8% | 3,250,000 | 0.0% | 0.18% | +11.5% | |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $20,579,000 | -16.8% | 773,348 | -41.8% | 0.18% | -42.1% |
| KDNY | New | CHINOOK THERAPEUTICS INC | $19,825,000 | – | 1,250,001 | +100.0% | 0.17% | – |
| LRMR | LARIMAR THERAPEUTICS INC | $18,981,000 | +41.1% | 886,560 | 0.0% | 0.17% | -1.8% | |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $18,675,000 | +7.1% | 1,935,200 | 0.0% | 0.16% | -25.6% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $17,032,000 | +48.7% | 1,479,733 | 0.0% | 0.15% | +3.5% | |
| SYRS | New | SYROS PHARMACEUTICALS INC | $16,953,000 | – | 1,562,500 | +100.0% | 0.15% | – |
| PCVX | Sell | VAXCYTE INC | $16,746,000 | -47.1% | 630,260 | -1.6% | 0.15% | -63.1% |
| CMPS | COMPASS PATHWAYS PLCsponsored ads | $16,674,000 | +36.5% | 350,000 | 0.0% | 0.15% | -5.2% | |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $16,704,000 | +491.5% | 2,493,109 | +546.2% | 0.15% | +317.1% |
| IMGN | New | IMMUNOGEN INC | $16,473,000 | – | 2,553,900 | +100.0% | 0.14% | – |
| ZYME | Sell | ZYMEWORKS INC | $14,982,000 | -5.7% | 317,002 | -7.1% | 0.13% | -34.5% |
| PHGE | BIOMX INC | $14,760,000 | +0.6% | 2,313,489 | 0.0% | 0.13% | -29.9% | |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $14,550,000 | – | 7,500,000 | +100.0% | 0.13% | – |
| RLAY | RELAY THERAPEUTICS INC | $14,546,000 | -2.4% | 350,000 | 0.0% | 0.13% | -32.1% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $14,208,000 | +221.9% | 265,772 | +148.4% | 0.12% | +125.5% |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $14,063,000 | – | 255,600 | +100.0% | 0.12% | – |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $12,930,000 | – | 150,000 | +100.0% | 0.11% | – |
| BLU | Sell | BELLUS HEALTH INC NEW | $12,573,000 | +7.2% | 4,189,593 | -18.4% | 0.11% | -25.2% |
| GILD | GILEAD SCIENCES INC | $11,198,000 | -7.8% | 192,200 | 0.0% | 0.10% | -35.9% | |
| AVRO | AVROBIO INC | $11,064,000 | +7.1% | 793,712 | 0.0% | 0.10% | -25.4% | |
| TARA | PROTARA THERAPEUTICS INC | $10,895,000 | +43.8% | 450,000 | 0.0% | 0.10% | 0.0% | |
| VTRS | New | VIATRIS INC | $10,029,000 | – | 535,149 | +100.0% | 0.09% | – |
| NRIX | NURIX THERAPEUTICS INC | $9,864,000 | -5.8% | 300,000 | 0.0% | 0.09% | -34.8% | |
| LUNG | New | PULMONX CORP | $8,628,000 | – | 125,000 | +100.0% | 0.08% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $8,525,000 | – | 50,000 | +100.0% | 0.08% | – |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $8,479,000 | +15.7% | 3,489,369 | 0.0% | 0.07% | -19.6% | |
| NBTX | New | NANOBIOTIX SAsponsored ads | $8,250,000 | – | 500,000 | +100.0% | 0.07% | – |
| INZY | INOZYME PHARMA INC | $8,264,000 | -21.5% | 400,400 | 0.0% | 0.07% | -45.5% | |
| HCAT | HEALTH CATALYST INC | $7,818,000 | +18.9% | 179,598 | 0.0% | 0.07% | -18.1% | |
| TCRR | New | TCR2 THERAPEUTICS INC | $7,710,000 | – | 249,279 | +100.0% | 0.07% | – |
| STRO | New | SUTRO BIOPHARMA INC | $7,599,000 | – | 350,000 | +100.0% | 0.07% | – |
| DYN | DYNE THERAPEUTICS INC | $7,350,000 | +4.0% | 350,000 | 0.0% | 0.06% | -28.1% | |
| COGT | New | COGENT BIOSCIENCES INC | $7,356,000 | – | 655,000 | +100.0% | 0.06% | – |
| OM | OUTSET MED INC | $7,105,000 | +13.7% | 125,000 | 0.0% | 0.06% | -21.5% | |
| XFOR | X4 PHARMACEUTICALS INC | $6,986,000 | -5.0% | 1,086,493 | 0.0% | 0.06% | -33.7% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $6,405,000 | +16.5% | 500,000 | 0.0% | 0.06% | -18.8% | |
| AKUS | AKOUOS INC | $6,246,000 | -13.3% | 315,000 | 0.0% | 0.06% | -39.6% | |
| EPIX | Sell | ESSA PHARMA INC | $5,494,000 | -32.4% | 460,500 | -60.9% | 0.05% | -52.9% |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $5,181,000 | – | 125,000 | +100.0% | 0.04% | – |
| ARPO | AERPIO PHARMACEUTICALS INC | $5,090,000 | -34.7% | 5,193,946 | 0.0% | 0.04% | -54.1% | |
| SYBX | SYNLOGIC INC | $4,385,000 | +6.9% | 2,029,996 | 0.0% | 0.04% | -26.9% | |
| FBRX | Sell | FORTE BIOSCIENCES INC | $3,357,000 | -79.7% | 92,200 | -72.9% | 0.03% | -86.1% |
| IFRX | Sell | INFLARX NV | $2,797,000 | -3.3% | 556,025 | -18.1% | 0.02% | -33.3% |
| MASS | New | 908 DEVICES INC | $2,278,000 | – | 40,000 | +100.0% | 0.02% | – |
| SELB | Sell | SELECTA BIOSCIENCES INC | $1,634,000 | -68.5% | 539,169 | -74.3% | 0.01% | -78.5% |
| PPBT | New | PURPLE BIOTECH LTDsponsored ads | $1,319,000 | – | 346,197 | +100.0% | 0.01% | – |
| CALA | New | CALITHERA BIOSCIENCES INCput | $1,229,000 | – | 250,300 | +100.0% | 0.01% | – |
| NVUS | New | NOVUS THERAPEUTICS INC | $1,105,000 | – | 73,650 | +100.0% | 0.01% | – |
| BMYRT | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $276,000 | -69.3% | 400,000 | 0.0% | 0.00% | -81.8% | |
| BLRX | Exit | BIOLINERX LTDsponsored ads | $0 | – | -69,240 | -100.0% | -0.00% | – |
| CALT | Exit | CALLIDITAS THERAPEUTICS ABsponsered ads | $0 | – | -17,696 | -100.0% | -0.01% | – |
| MYOV | Exit | MYOVANT SCIENCES LTDcall | $0 | – | -50,000 | -100.0% | -0.01% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -2,644,600 | -100.0% | -0.02% | – | |
| KTOV | Exit | KITOV PHARMA LTDsponsord ads new | $0 | – | -346,197 | -100.0% | -0.02% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -63,860 | -100.0% | -0.02% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -180,442 | -100.0% | -0.03% | – |
| OBSV | Exit | OBSEVA SA | $0 | – | -1,303,000 | -100.0% | -0.04% | – |
| KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.04% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -66,700 | -100.0% | -0.06% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -364,500 | -100.0% | -0.06% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -253,108 | -100.0% | -0.07% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -625,000 | -100.0% | -0.12% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -328,385 | -100.0% | -0.14% | – |
| ANNX | Exit | ANNEXON INC | $0 | – | -379,947 | -100.0% | -0.14% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -125,000 | -100.0% | -0.18% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -3,411,806 | -100.0% | -0.24% | – |
| NVO | Exit | NOVO-NORDISK A Sadr | $0 | – | -330,000 | -100.0% | -0.29% | – |
| PFE | Exit | PFIZER INCcall | $0 | – | -750,000 | -100.0% | -0.35% | – |
| NVUS | Exit | NOVUS THERAPEUTICS INC | $0 | – | -3,183,314 | -100.0% | -0.68% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -2,404,100 | -100.0% | -0.74% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -601,066 | -100.0% | -0.85% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
| 3 | 2024-03-27 |
| SC 13D/A | 2024-03-22 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.